Who is Teriparatide Injection suitable for?

Teriparatide injection is indicated for patients with many types of osteoporosis, especially those who are at high risk for fractures. It is primarily used to treat osteoporosis in postmenopausal women and men. For patients with significantly reduced bone density due to osteoporosis and a history of fractures, teriparatide can significantly reduce the risk of future fractures, especially fractures in key locations such as the spine and hip. Teriparatide is an important treatment option when these patients often have already received other treatments (eg, antiresorptive drugs) that have failed to prevent fractures.

In addition, teriparatide injection is also suitable for patients with osteoporosis caused by long-term use of corticosteroids. Long-term use of steroid drugs can inhibit bone formation and increase the risk of fractures, especially in patients with low bone density. Teriparatide can help reverse this damage by promoting bone formation to increase bone density and reduce the risk of steroid-related fractures. Therefore, teriparatide is an effective intervention in patients receiving long-term steroid therapy.

Teriparatide is also indicated for patients who are at higher risk for fractures, including those whose osteoporosis treatments have failed to respond or fail to improve bone density. For those patients with osteoporosis and a history of fractures, teriparatide injection can effectively reduce the risk of fractures caused by osteoporosis by increasing bone density and improving bone quality, especially in vulnerable parts such as the spine and hips.

However, teriparatide is not suitable for all patients. Teriparatide should be avoided in those patients with hypercalcemia, bone tumors or bone metastases, or in patients with severe renal disease. In addition, the use of teriparatide should be carried out under the guidance of a doctor, and the use period usually does not exceed two years to avoid possible side effects caused by long-term use. Therefore, patients need to be treated under strict supervision by a doctor when using teriparatide.